Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Medicaid drugs.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Poisal JA;Poisal JA
  • المصدر:
    Health care financing review [Health Care Financ Rev] 2004 Spring; Vol. 25 (3), pp. 1-4.
  • نوع النشر :
    Journal Article
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: U.S. Health Care Financing Administration Country of Publication: United States NLM ID: 7909994 Publication Model: Print Cited Medium: Print ISSN: 0195-8631 (Print) Linking ISSN: 01958631 NLM ISO Abbreviation: Health Care Financ Rev
    • بيانات النشر:
      Publication: [winter 1988] - : Baltimore, MD : U.S. Health Care Financing Administration
      Original Publication: [Washington, D.C. : U.S. Dept. of Health, Education, and Welfare, Health Care Financing Administration, Office of Research, Demonstrations, and Statistics], 1979-
    • الموضوع:
      Insurance, Pharmaceutical Services* ; Medicaid*; Drug Costs/*trends; Cost Control ; Health Services Accessibility ; Humans ; United States
    • نبذة مختصرة :
      The following commentary unites a collection of articles primarily concerned with prescription drug issues in Medicaid. It also features highlights from a piece outlining Australia's pharmaceutical delivery system. Specifically, in this issue, you will find comprehensive analyses of drug expenditure trends, issues regarding access to pharmaceuticals in Medicaid, and an evaluation of ongoing generic drug cost-containment programs.
    • References:
      Health Aff (Millwood). 2003 Jul-Dec;Suppl Web Exclusives:W3-521-36. (PMID: 15506157)
    • الموضوع:
      Date Created: 20040703 Date Completed: 20040806 Latest Revision: 20181113
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC4194864
    • الرقم المعرف:
      15229992